Zantac Generics MDL Labeling Claims Axed As Preempted
A Florida federal judge presiding over sprawling multidistrict litigation over the carcinogens found in the popular heartburn medication Zantac has held that state labeling and design defect claims against Zantac generics...To view the full article, register now.
Already a subscriber? Click here to view full article